Updated results from a phase Ib/II study in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) treated with polatuzumab vedotin (pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G) Meeting Abstract
| Authors: | McMillan, A.; Sehn, L.; Herrera, A.; Matasar, M.; Kamdar, M.; Assouline, S.; Hertzberg, M.; Kim, T. M.; Kim, W. S.; Ozcan, M.; Hirata, J.; Penuel, E.; Cheng, J.; Ku, G.; Flowers, C. |
| Abstract Title: | Updated results from a phase Ib/II study in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) treated with polatuzumab vedotin (pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G) |
| Meeting Title: | 59th Annual Scientific Meeting of the British Society for Hematology |
| Keywords: | dlbcl; polatuzumab |
| Journal Title: | British Journal of Haematology |
| Volume: | 185 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Apr 1-3 |
| Meeting Location: | Glasgow, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2019-03-01 |
| Start Page: | 80 |
| Language: | English |
| ACCESSION: | WOS:000462529200118 |
| PROVIDER: | wos |
| PUBMED: | 30916380 |
| DOI: | 10.1111/bjh.15854 |
| Notes: | Meeting Abstract: BSH19-PO-079 -- Source: Wos |
